This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA471673; GEO: GSE114522 |
| Type | Umbrella project |
| Publications | Liu CF et al., "SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.", Development, 2018 Jul 18;145(14) |
| Submission | Registration date: 16-May-2018
NC1-147, Cellular & Molecular Medicine, Cleveland Clinic Lerner Research Institute |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 37 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 37 |
| GEO DataSets | 3 |
SOX9 is dispensable to initiate epigenetic remodeling and activation of marker genes at the onset of chondrogenesis encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA471677 | Mus musculus | SOX9 is dispensable to initiate epigenetic remodeling and activation of marker genes at the onset of chondrogenesis (ChIP-Seq) (NC1-147, Cellular & Molecular...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA471676 | Mus musculus | SOX9 is dispensable to initiate epigenetic remodeling and activation of marker genes at the onset of chondrogenesis (RNA-Seq) (NC1-147, Cellular & Molecular...) |
|